Dopamine-d5 hydrochloride

Modify Date: 2024-01-05 20:26:20

Dopamine-d5 hydrochloride Structure
Dopamine-d5 hydrochloride structure
Common Name Dopamine-d5 hydrochloride
CAS Number 2193106-55-5 Molecular Weight 194.67
Density N/A Boiling Point N/A
Molecular Formula C8H7D5ClNO2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Dopamine-d5 hydrochloride


Dopamine-d5 hydrochloride is the deuterium labeled Dopamine (hydrochloride). Dopamine hydrochloride (ASL279) is a catecholamine neurotransmitter that is produced in the substantia nigra, ventral tegmental area, and hypothalamus of the brain. Dopamine hydrochloride (ASL279) plays several important roles in the brain and body[1]. Dopamine hydrochloride (ASL279) acts through D2 dopamine receptors to induce endocytosis of VEGFR2, which is critical for promoting angiogenesis[1].

 Names

Name Dopamine-d5 hydrochloride

 Dopamine-d5 hydrochloride Biological Activity

Description Dopamine-d5 hydrochloride is the deuterium labeled Dopamine (hydrochloride). Dopamine hydrochloride (ASL279) is a catecholamine neurotransmitter that is produced in the substantia nigra, ventral tegmental area, and hypothalamus of the brain. Dopamine hydrochloride (ASL279) plays several important roles in the brain and body[1]. Dopamine hydrochloride (ASL279) acts through D2 dopamine receptors to induce endocytosis of VEGFR2, which is critical for promoting angiogenesis[1].
Related Catalog
In Vitro Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

[2]. Juárez Olguín H, et al. The Role of Dopamine and Its Dysfunction as a Consequence of Oxidative Stress. Oxid Med Cell Longev. 2016;2016:9730467.

[3]. Basu S, et al. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat Med. 2001 May;7(5):569-74.

 Chemical & Physical Properties

Molecular Formula C8H7D5ClNO2
Molecular Weight 194.67